IRWD : Summary for Ironwood Pharmaceuticals, Inc. - Yahoo Finance

U.S. Markets close in 30 mins.

Ironwood Pharmaceuticals, Inc. (IRWD)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
16.39-0.42 (-2.50%)
As of 3:30PM EST. Market open.
People also watch
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Previous Close16.81
Bid16.43 x 200
Ask16.44 x 1300
Day's Range16.35 - 16.77
52 Week Range9.06 - 17.49
Avg. Volume1,230,763
Market Cap2.4B
PE Ratio (TTM)-28.70
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Business Wire23 hours ago

    Ironwood Pharmaceuticals to Host R&D Day on March 9, 2017

    Ironwood Pharmaceuticals, Inc. will host a live webcast of its R&D Day on Thursday, March 9, 2017 beginning at 9:00 a.m. Eastern Time. Members of the Ironwood leadership team and external opinion leaders will provide R&D and commercial insights into key Ironwood product opportunities.

  • Ironwood (IRWD) Q4 Loss Narrower than Expected; Sales Top
    Zacks2 days ago

    Ironwood (IRWD) Q4 Loss Narrower than Expected; Sales Top

    Ironwood Pharmaceuticals, Inc. (IRWD) reported an adjusted loss of 12 cents per share in the fourth quarter of 2016, narrower than the Zacks Consensus Estimate of a loss of 23 cents but slightly wider than the year-ago loss of 11 cents.

  • Associated Press3 days ago

    Ironwood reports 4Q loss

    On a per-share basis, the Cambridge, Massachusetts-based company said it had a loss of 9 cents. Losses, adjusted for amortization gains and non-recurring gains, were 12 cents per share. The results exceeded ...